NCT06612190

Evaluation on Visual Outcome of TMS

Evaluation on Visual Outcome of Transcranial Magnetic Stimulation

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: Evidence Based Cataract Study Group · Academic / Other
• Sex: All
• Age: 6 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to learn if transcranial magnetic stimulation (TMS) can improve the visual outcomes in patients with visual impairment. The main question it aims to answer is: • Does TMS improve the visual outcome in patients who suffer from visual impairment? Researchers will compare TMS to the control group who will not receive effective TMS treatment) to see if TMS works to improve the visual outcomes of the patients. Participants will * Undergo TMS treatment or no effective TMS for consecutive 5 days. * Visit the clinic once every 2 weeks for checkups and tests.

Conditions

• Visual Impairment

Interventions

Type	Name	Description
PROCEDURE	TMS	TMS treatment in this study indicates a non-invasive procedure called transcranial magnetic simulation (TMS) on visual cortex. The treatment intensity is set as 80% of the threshold of each participant. The treatment will be conducted every day for consecutive 5 days.
PROCEDURE	Control	The sham group will be given no real magnetic stimulation.

Timeline

• Start date: 2024-10-01
• Primary completion: 2025-10-01
• Completion: 2027-10-01
• First posted: 2024-09-25
• Last updated: 2024-09-25

Locations

1 site across 1 country: China